SCHEMBL17586258

SCHEMBL17586258

CNC12CC(C(C)(C)O)(C1)C2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17586284 0.78 GRIN2D (0.32)
SCHEMBL7463097 0.76
SCHEMBL17586261 0.72 HPGDS (0.37)
SCHEMBL22369864 0.70 GRIN2D (0.31)
SCHEMBL19566928 0.69 GRIN2D (0.42)
SCHEMBL16450714 0.69 GRIN2D (0.42)
SCHEMBL17586259 0.69 PKM (0.31)
SCHEMBL21504185 0.69
SCHEMBL7460167 0.67
SCHEMBL7461807 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024137607-A1 THIADIAZOLE DERIVATIVES AS INHIBITORS OF CYCLIC GMP-AMP SYNTHASE AND USES THEREOF VENTUS THERAPEUTICS U.S., INC. (US) 2024-06-27 WO disclosed
EP-3193855-B1 BICYCLIC COMPOUNDS RECURIUM IP HOLDINGS LLC (US) 2021-05-19 EP disclosed
US-10975035-B2 Bicyclic compounds RECURIUM IP HOLDINGS, LLC (US) 2021-04-13 US disclosed
US-20190233377-A1 BICYCLIC COMPOUNDS Zeno Royalties & Milestones, LLC 2019-08-01 US disclosed
US-10308609-B2 Bicyclic compounds Zeno Royalties & Milestones, LLC (US) 2019-06-04 US disclosed
US-20160075654-A1 BICYCLIC COMPOUNDS RECURIUM IP HOLDINGS, LLC 2016-03-17 US disclosed